Institutional HoldersBeta

Who holds a company, from every 13F filed for the quarter, one row per filer exactly as filed, against the latest share count the company reported.

Basel Medical Group Ltd

CIK 0002004489BMGL· quarter ending 2026-06-30
Shares outstanding
18,785,750
Held by 13F filers
499
0.0% of shares outstanding
Holders
2
+2 vs 2026-03-31 · 2 new, 0 exited
Value
$3K
shares +— vs prior quarter

Share classes (cover page of the 20-F/A filed 2026-03-13, as of 2025-06-30)

ClassListedShares outstandingHeld by 13F filers% of classHoldersCUSIP
Common stockBMGL · NASDAQ18,785,7504990.0%2G0864B111

Each class is compared with its own share count; classes are not added together. A class that is not exchange-listed cannot be held by 13F filers.

Securities (CUSIPs held in 13F this quarter)

tick to combine
CountCUSIPClass (as filers write it)HoldersShares heldClass shares% of classValueOptionsMapped via
G0864B111ORD SHS249918,785,7500.0%$3K—prefixholders →

Totals combine the ticked CUSIPs and update as you tick: common-stock classes by default; preferreds, notes, warrants and depositary shares are listed but not counted. "holders →" shows a single CUSIP on its own. Bonds are held as a principal amount, not shares. Options positions are never counted as holdings. 1 further CUSIPs map to this company (mostly bonds) but no 13F filer held them this quarter.

Top holders (2 of 2 · G0864B111)

change vs 2026-03-31
#FilerShares% of classValueChange
1UBS Group AG4950.00%$3KNEW
2Coston, McIsaac & Partners40.00%$0NEW

Large holders from 13D/13G (latest per reporting person, last 2 years)

Filed when a holder crosses 5% or changes materially, so often more current than the quarter-end 13F. Percentages are the filer's own, against the share count they used.

Reporting personFormFiledEventShares% of class
Keng Leong FungSCHEDULE 13G2025-04-302025-02-2110,174,57954.2%
Mengli ChenSCHEDULE 13G2025-04-302025-02-2110,174,57954.2%
Rainforest Capital VCCSCHEDULE 13G2025-04-302025-02-2110,174,57954.2%

Source: SEC Form 13F-HR information tables for the quarter ending 2026-06-30 (filed within 45 days of quarter end; amendments applied; values normalised to dollars), the share count from the company's latest 10-K/10-Q XBRL cover page, and Schedule 13D/13G filings. Each row is a legal 13F filer as filed — related entities (e.g. Vanguard's advisers) are not merged. Retail brokerage accounts are not reported on 13F, so the remainder is mostly retail and insiders.